We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
-15.33%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$1.87B
AUM Growth
-$449M
(-19%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-3.14%
Top 10 Holdings %
Top 10 Hldgs %
33.16%
Holding
358
New
37
Increased
55
Reduced
86
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$48.3M |
| 2 |
UnitedHealth
UNH
|
+$32.7M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$19.2M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.8M |
| 5 |
CME Group
CME
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$39.5M |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$26.5M |
| 3 |
Freeport-McMoran
FCX
|
+$17.7M |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
+$17.1M |
| 5 |
Regal Rexnord
RRX
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Healthcare | 15.76% |
| 3 | Consumer Discretionary | 13.02% |
| 4 | Financials | 12.7% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
SiTime
SITM
$13.8B
| $3.25M | 0.17% |
+19,910
| New | +$3.76M |
|
127
Insmed
INSM
$22.4B
| $3.24M | 0.17% |
164,350
-4,370
| -3% | -$91.6K |
|
128
Visteon
VC
$2.85B
| $3.22M | 0.17% |
+31,120
| New | +$3.21M |
|
129
American Express
AXP
$224B
| $3.19M | 0.17% |
22,975
| – | – |
|
|
AYX
130
DELISTED
Alteryx Inc
AYX
| $3.14M | 0.17% |
+64,760
| New | +$3.87M |
|
131
Sterling Infrastructure
STRL
$15.2B
| $3.09M | 0.17% |
141,104
+2,620
| +2% | +$63K |
|
|
SUM
132
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $3.01M | 0.16% |
131,513
-184,433
| -58% | -$4.9M |
|
133
Plains All American Pipeline
PAA
$17.6B
| $3.01M | 0.16% |
306,649
| – | – |
|
134
Synaptics
SYNA
$4.05B
| $3M | 0.16% |
25,436
-22,175
| -47% | -$3.25M |
|
|
FOCS
135
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $3M | 0.16% |
88,110
-45,000
| -34% | -$1.72M |
|
136
EQT Corp
EQT
$32.9B
| $2.95M | 0.16% |
85,710
-41,310
| -33% | -$1.7M |
|
137
Pacira BioSciences
PCRX
$1.04B
| $2.89M | 0.15% |
49,580
-11,080
| -18% | -$726K |
|
138
Marathon Petroleum
MPC
$90.1B
| $2.76M | 0.15% |
33,579
| – | – |
|
139
Semtech
SMTC
$9.65B
| $2.73M | 0.15% |
49,748
-2,198
| -4% | -$133K |
|
140
Cal-Maine
CALM
$4.43B
| $2.53M | 0.14% |
51,220
-2,330
| -4% | -$118K |
|
141
Glaukos
GKOS
$9.49B
| $2.52M | 0.13% |
55,400
-9,440
| -15% | -$448K |
|
142
Delek US
DK
$3.98B
| $2.49M | 0.13% |
+96,450
| New | +$2.6M |
|
|
CTRA
143
DELISTED
Coterra Energy
CTRA
| $2.35M | 0.13% |
90,930
| – | – |
|
144
ConocoPhillips
COP
$144B
| $2.33M | 0.13% |
26,002
| – | – |
|
|
DCP
145
DELISTED
DCP Midstream, LP
DCP
| $2.23M | 0.12% |
75,565
| – | – |
|
146
Green Plains
GPRE
$1.15B
| $2.21M | 0.12% |
81,408
-63,857
| -44% | -$2M |
|
|
MRO
147
DELISTED
Marathon Oil Corporation
MRO
| $2.21M | 0.12% |
98,110
-640,400
| -87% | -$17.1M |
|
|
P
148
Everpure Inc
P
$23B
| $2.18M | 0.12% |
84,800
-69,890
| -45% | -$1.93M |
|
149
Tenaris
TS
$28.2B
| $2.18M | 0.12% |
84,820
| – | – |
|
|
SWIR
150
DELISTED
Sierra Wireless
SWIR
| $2.17M | 0.12% |
+92,540
| New | +$1.82M |
|
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q2 2022 Portfolio in Review
As of Q2 2022, Castleark Management held 358 positions worth $1.87B, down 19% from $2.32B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Castleark Management withdrew a net $58.7M in Q2 2022, closing 52 positions and reducing 86 holdings. Its most notable exit was State Street Materials Select Sector SPDR ETF, an estimated $26.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in State Street SPDR S&P Biotech ETF worth $47.8M.
- Castleark Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 643,890 shares worth $47.8M.
- Castleark Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.8M increase.
- Castleark Management's biggest Q2 2022 reduction was Microchip Technology, cutting an estimated $39.5M.
- Castleark Management fully exited State Street Materials Select Sector SPDR ETF in Q2 2022, selling an estimated $26.5M.
- Castleark Management's ten largest holdings make up 33% of its $1.87B portfolio in Q2 2022.
- Castleark Management opened 37 new positions and closed 52 in Q2 2022.
- Castleark Management's portfolio value fell 19% quarter-over-quarter to $1.87B.
Based on Castleark Management's 13F filing for Q2 2022, filed 16 Aug 2022.